Blink Charging Co (NASDAQ: BLNK) has reported a loss for its third fiscal quarter (ending September 30) of $-0.51 versus a loss $-0.36 for the same period a year ago. This performance was $-0.05 short […]
TripAdvisor Inc (NASDAQ: TRIP) stock suffered a major decline of -17.3% on 11/8/22. The shares closed at $19.68. Moreover, exceptionally high trading volume at 721% of normal accompanied the decline. The stock has declined -16.7% […]
Xenon Pharmaceuticals Inc (NASDAQ: XENE) has reported E.P.S. of $-0.57 for its third fiscal quarter (ending September 30) versus $-0.37 for the same period a year ago. Relative to the consensus estimate of $-0.51, this […]
FibroGen Inc (NASDAQ: FGEN) stock suffered a major decline of -12.4% on 11/8/22. The shares closed at $14.15. Moreover, trading volume in this decline was unusually high at 199% of normal. The stock has been […]
Revance Therapeutics Inc (NASDAQ: RVNC) has reported a loss for its third fiscal quarter (ending September 30) of $-1.17 versus a loss $-1.10 for the same period a year ago. This result fell short of […]
© 2019 PriceTarget Research